| Gene Symbol | OVERVIEW |
| Pathways | Adaptive Immunity, Akt, Angiogenesis, Apoptosis, Autophagy |
| GeneCards | OVERVIEW |
| Human Protein Atlas | OVERVIEW |
| Precision | Assessment of assay reproducibility within and between laboratories using standardized protocols. |
| Accuracy | Comparison of biomarker measurements against gold-standard methods. |
| Stability | Evaluation of biomarker degradation under various pre-analytical conditions. |
| Diagnostic accuracy | Sensitivity, specificity, and predictive values for distinguishing disease from controls. |
| Disease progression markers | Correlation of biomarker levels with clinical decline and neuroimaging changes. |
| Treatment response biomarkers | Ability to detect pharmacodynamic effects and predict clinical benefit. |
| Enrichment | Selecting patients based on biomarker-positive status for targeted therapies. |
| Stratification | Subgrouping patients by biomarker profiles to identify treatment responders. |
| Endpoint selection | Using biomarker changes as surrogate endpoints for clinical outcomes. |
| Mechanistic confirmation | Demonstrating target engagement and biological activity of investigational therapies. |
| Associated Diseases | Addiction, aging, Als, Alzheimer |
| Interactions | ACETYL-COA, Actin, AGING, AKT, ALS, ALZHEIMER |
| KG Connections | 2123 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
No AI portrait yet
No comments yet. Be the first to comment!